Patent US4948575A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4948575A Expired / Lapsed US ⏱️ 0.0 years remaining

Alginate hydrogel foam wound dressing

Assignee: 3M Co
•
Filing: 1989-01-24
•
Granted: 1990-08-14
•
Expires: 2009-01-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A dimensionally stable alginate hydrogel foam wound dressing that absorbs wound exudate without any appreciable swelling. The wound dressing is formed-in-place in the wound cavity or on the wound surface from a reactive composition that foams as it gels. The water-insoluble alginate hydrogel foam based wound dressing is made by mixing together the ingredients of a two component system; applying the resulting composite liquid mixture to a wound site; and allowing the composite mixture to react. One component contains an aqueous suspension of certain di-or trivalent metal salts and an effervescent compound. The second component contains an aqueous solution of a biocompatible, water-soluble acid. At least one compound, and preferably both, contain a water soluble alginate.

Inventors

  • 👤 Susan M. Cole
  • 👤 James E. Garbe

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:04
CPC Classifications
A; A61; A61L; A61L26/00; A61L26/0061; A61L26/008; A61L26/0009; A61L26/0023; Y; Y10; Y10S; Y10S424/00; Y10S424/13

Claims Analysis

Total Claims: 31
Claim 1
Independent Claim 140 words
A method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing comprising the steps of: (I) mixing together, to form a composite liquid mixture, a first liquid component comprising: (a) an aqueous suspension of particles of a water-insoluble di- or trivalent metal salt that will react with an acid to form a water-soluble metal salt, and which has a di- or trivalent metal ion capable of complexing with pendant carboxylate groups on water-soluble alginates to form water-insoluble alginate hydrogels, and (b) an effervescent compound which effervesces upon reaction with an acid; and a second liquid component comprising an aqueous solution of a biocompatible, water-soluble acid, wherein at least one of said components further comprise water-soluble alginate dissolved therein; (II) applying said composite liquid mixture directly to a wound site; and (III) allowing said composite liquid mixture to react.
Claim 2
Independent Claim 140 words
A method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing comprising the steps of: (I) mixing together, to form a composite liquid mixture, a first liquid component comprising: (a) an aqueous suspension of particles of a water-insoluble di- or trivalent metal salt that will react with an acid to form a water-soluble metal salt, and which has a di- or trivalent metal ion capable of complexing with pendant carboxylate groups on water-soluble alginates to form water-insoluble alginate hydrogels, and (b) an effervescent compound which effervesces upon reaction with an acid; and a second liquid component comprising an aqueous solution of a biocompatible, water-soluble acid, wherein at least one of said components further comprise water-soluble alginate dissolved therein; (II) applying said composite liquid mixture directly to a wound site; and (III) allowing said composite liquid mixture to react.
Claim 3
Independent Claim 127 words
A method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing comprising the steps of: (I) mixing together a first liquid component comprising: (a) water, (b) water-soluble alginate, (c) water-insoluble di- or trivalent metal salt that will react with an acid to form a water-soluble metal salt, and which has a di- or trivalent metal ion capable of complexing with pendant carboxylate groups on said water-soluble alginate to form a water-insoluble alginate hydrogel, and (d) an effervescent compound which effervesces upon reaction with an acid; and a second liquid component comprising an aqueous solution of a biocompatible, water-soluble acid, to form a composite liquid mixture; (II) applying said composite liquid mixture directly to a wound site; and (III) allowing said composite liquid mixture to react.
Claim 4
Independent Claim 127 words
A method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing comprising the steps of: (I) mixing together a first liquid component comprising: (a) water, (b) water-soluble alginate, (c) water-insoluble di- or trivalent metal salt that will react with an acid to form a water-soluble metal salt, and which has a di- or trivalent metal ion capable of complexing with pendant carboxylate groups on said water-soluble alginate to form a water-insoluble alginate hydrogel, and (d) an effervescent compound which effervesces upon reaction with an acid; and a second liquid component comprising an aqueous solution of a biocompatible, water-soluble acid, to form a composite liquid mixture; (II) applying said composite liquid mixture directly to a wound site; and (III) allowing said composite liquid mixture to react.
Claim 5
Dependent Claim 40 words
The method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing as recited in claim 2 wherein said water-soluble alginate is selected from the group consisting of the ammonium, magnesium, potassium, sodium, and lithium salts of alginic acid.
Claim 6
Dependent Claim 34 words
The method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing as recited in claim 2 wherein said water-soluble alginate is selected from the group consisting of sodium alginate and potassium alginate.
Claim 7
Dependent Claim 43 words
The method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing as recited in claim 2 wherein said water-insoluble di- or trivalent metal salt is selected from the group consisting of calcium carbonate, calcium phosphate dibasic, barium carbonate and zinc carbonate.
Claim 8
Dependent Claim 27 words
The method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing as recited in claim 2 wherein said water-insoluble divalent metal salt is calcium carbonate.
Claim 9
Dependent Claim 37 words
The method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing as recited in claim 2 wherein said biocompatible, water-soluble acid is selected from the group consisting of acetic, lactic, malic, gluconic, and ascorbic acids.
Claim 10
Dependent Claim 26 words
The method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing as recited in claim 2 wherein said second component further comprises water-soluble alginate.
Claim 11
Dependent Claim 34 words
The method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing as recited in claim 8 wherein the water-soluble alginate in both said first and second components is of the same composition.
Claim 12
Dependent Claim 34 words
The method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing as recited in claim 9 wherein said water-soluble alginate is selected from the group consisting of sodium alginate and potassium alginate.
Claim 13
Dependent Claim 33 words
The method of making, in situ, a water-insoluble alginate, hydrogel foam wound dressing as recited in claim 2 wherein said effervescent compound is selected from the group consisting of the alkali metal carbonates.
Claim 14
Dependent Claim 25 words
The method of making, in situ, a water-insoluble alginate, hydrogel foam wound dressing as recited in claim 2 wherein said effervescent compound is sodium carbonate.
Claim 15
Dependent Claim 13 words
An alginate hydrogel foam wound dressing prepared by the method of claim 1.
Claim 16
Dependent Claim 13 words
An alginate hydrogel foam wound dressing prepared by the method of claim 2.
Claim 17
Dependent Claim 13 words
An alginate hydrogel foam, wound dressing prepared by the method of claim 3.
Claim 18
Dependent Claim 13 words
An alginate hydrogel foam wound dressing prepared by the method of claim 4.
Claim 19
Dependent Claim 13 words
An alginate hydrogel foam wound dressing prepared by the method of claim 5.
Claim 20
Dependent Claim 13 words
An alginate hydrogel foam wound dressing prepared by the method of claim 10.
Claim 21
Dependent Claim 13 words
An alginate hydrogel foam wound dressing prepared by the method of claim 7.
Claim 22
Dependent Claim 12 words
An hydrogel foam wound dressing prepared by the method of claim 8.
Claim 23
Dependent Claim 13 words
An alginate hydrogel foam wound dressing prepared by the method of claim 13.
Claim 24
Dependent Claim 13 words
An alginate hydrogel foam wound dressing prepared by the method of claim 10.
Claim 25
Dependent Claim 13 words
An alginate hydrogel foam wound dressing prepared by the method of claim 11.
Claim 26
Dependent Claim 13 words
An alginate hydrogel foam wound dressing prepared by the method of claim 12.
Claim 27
Independent Claim 78 words
A method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing comprising the steps of: (I) mixing together a first liquid component comprising: (a) water, (b) sodium alginate, (c) calcium carbonate, and (d) sodium carbonate; and a second liquid component comprising: (e) water, (f) acetic acid, and (g) sodium alginate, to form a composite liquid mixture; (II) applying said composite liquid mixture directly to a wound site; and (III) allowing said composite liquid mixture to react.
Claim 28
Independent Claim 78 words
A method of making, in situ, a water-insoluble alginate hydrogel foam wound dressing comprising the steps of: (I) mixing together a first liquid component comprising: (a) water, (b) sodium alginate, (c) calcium carbonate, and (d) sodium carbonate; and a second liquid component comprising: (e) water, (f) acetic acid, and (g) sodium alginate, to form a composite liquid mixture; (II) applying said composite liquid mixture directly to a wound site; and (III) allowing said composite liquid mixture to react.
Claim 29
Dependent Claim 13 words
An alginate hydrogel foam wound dressing prepared by the method of claim 25.
Claim 30
Dependent Claim 137 words
An alginate hydrogel foam wound dressing made by the process comprising the steps of: (I) mixing together, to form a composite liquid mixture, a first liquid component comprising: (a) an aqueous suspension of particles of a water-insoluble di- or trivalent metal salt that will react with an acid to form a water-soluble metal salt, and which has a di- or trivalent metal ion capable of complexing with pendant carboxylate groups on water-soluble alginates to form water-insoluble alginate hydrogels, and (b) an effervescent compound with effervesces upon reaction with an acid; and a second liquid component comprising an aqueous solution of a biocompatible, water-soluble acid, wherein at least one of said components further comprise water-soluble alginate dissolved therein; (II) applying said composite liquid mixture directed to a wound site; and (III) allowing said composite liquid mixture to react.
Claim 31
Dependent Claim 137 words
An alginate hydrogel foam wound dressing made by the process comprising the steps of: (I) mixing together, to form a composite liquid mixture, a first liquid component comprising: (a) an aqueous suspension of particles of a water-insoluble di- or trivalent metal salt that will react with an acid to form a water-soluble metal salt, and which has a di- or trivalent metal ion capable of complexing with pendant carboxylate groups on water-soluble alginates to form water-insoluble alginate hydrogels, and (b) an effervescent compound with effervesces upon reaction with an acid; and a second liquid component comprising an aqueous solution of a biocompatible, water-soluble acid, wherein at least one of said components further comprise water-soluble alginate dissolved therein; (II) applying said composite liquid mixture directed to a wound site; and (III) allowing said composite liquid mixture to react.

References Cited (Backward Citations)

US2688586A Cited
SE424956B Cited
US4401456A Cited
US4391799A Cited
US4393048A Cited
US4291025A Cited
EP0092329A2 Cited
US4704113A Cited
US4613497A Cited
GB2182663A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-08-13 1994-02-12 1994-08-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-08-13 1998-02-12 1998-08-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-08-13 2002-02-12 2002-08-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag